3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Surgery
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Interventions
pembrolizumab
14
Carboplatin
12
Specimen Handling
10
sacituzumab govitecan
6
Magnetic Resonance Spectroscopy
6
Capecitabine
6
Biopsy
6
Paclitaxel
5
Gemcitabine
5
Nivolumab
4
Cyclophosphamide
4
olaparib
3
Taxes
3
Fulvestrant
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Platinum
2
Letrozole
2
Immunoglobulin G
2
Epirubicin
2
Albumin-Bound Paclitaxel
2
zimberelimab
1
vistusertib
1
veliparib
1
tremelimumab
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.